Target intelligence / Profile preview

Novel transcript, antisense to SBF2 (ENSG00000305052)

Target
ENSG00000305052
Molecular classification
Long non-coding RNA (lncRNA), Antisense transcript
01

Overview

Novel transcript, antisense to SBF2 is a long non-coding RNA gene transcribed from the opposite strand of the SBF2 locus. As an antisense lncRNA, its transcript overlaps the SBF2 gene and may regulate SBF2 expression or processing via transcriptional interference, chromatin modification, or RNA duplex formation. No protein product has been identified. Its specific biological function, disease associations, and clinical relevance remain uncharacterized. There is no documented direct role for this specific antisense transcript in cancer, inflammation, neurodegenerative disease, or other pathologies; however, antisense lncRNAs in general can participate in disease mechanisms through gene regulation. This target is a non-coding RNA, not a protein; it is an uncharacterized antisense transcript that may regulate the nearby SBF2 gene but is not recognized as a direct therapeutic target, biomarker, or established disease gene.

Other names
Novel transcript, antisense to SBF2 (GeneCards official symbol: ENSG00000305052)
02

Biological functions

Can regulate transcription of overlapping/neighboring genes (cis-regulation)Can modulate chromatin structure or histone modificationsCan affect mRNA splicing, stability, or translation of sense transcripts
03

Disease associations

Other

Beyond the preview

Go deeper on Novel transcript, antisense to SBF2 (ENSG00000305052).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to SBF2 (ENSG00000305052).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call